Eloxx Pharmaceuticals Inc.
ELOX | NASDAQ
$13.45
+$0.27 (+2.05%)
At close: Oct 30, 2026, 4:00 PM ET
$13.79
+$0.34 (+2.53%)
Pre-market:
Nov 2, 2026, 7:12 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.06 | -1.19 | -0.15 | -0.06 | -0.03 | -0.03 |
PEG Ratio | 0.05 | 0.01 | 0 | 0 | 0 | 0 |
PS Ratio | n/a | 0.59 | n/a | n/a | n/a | n/a |
PB Ratio | -1.04 | -0.15 | -0.11 | -0.20 | 0.08 | 0.10 |
P/FCF Ratio | n/a | -0.80 | -0.18 | -0.07 | -0.05 | -0.04 |
P/OCF Ratio | -1.95 | -0.80 | -0.18 | -0.07 | -0.05 | -0.04 |
OCF/S Ratio | n/a | -74.15 | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -0.08 | -0.27 | -0.18 | -1.26 | 0.60 | 1.18 |
Quick Ratio | 0.31 | 0.11 | 0.07 | 0.87 | 4.37 | 2.63 |
Current Ratio | 0.31 | 0.11 | 0.07 | 0.87 | 4.37 | 2.63 |
Asset Turnover | n/a | 2.14 | n/a | n/a | n/a | n/a |
Interest Coverage | -6.14 | -2.16 | -15.02 | -17.66 | -33.64 | -20.89 |
Return on Equity | 50.35% | 12.92% | 75.46% | 338.32% | -298.10% | -338% |
Return on Assets | -113.76% | -105.61% | -996.14% | -170.74% | -147.83% | -130.59% |
Return on Invested Capital | 59.03% | 13.85% | 92.78% | -1.26K% | -118.16% | -132.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 100% | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | -49.43% | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | -49.43% | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | -38.81% | n/a | n/a | n/a | n/a |
FCF Margin | n/a | -74.15% | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -28.86% | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ELOX